Upheal offers an artificial intelligence–assisted platform designed for mental health professionals, automating clinical notes and providing analytics to streamline workflows. The product focuses on reducing administrative burden by saving clinicians time on note-taking and progress tracking. Upheal's platform includes AI-powered notes and analytics features tailored for individual and group therapy settings. The company plans to enhance its AI capabilities with customizable templates and add explicit group therapy support. It will also allocate resources to marketing, engineering, and further product development to expand the platform. Financially, Upheal secured a $3.25M seed round in February 2024 to support these efforts. The company was founded in 2021 and is based in New York. Upheal has launched an AI-powered "smart notebook" for therapists and coaches that combines high-quality video calling, automated full-session transcripts and pre-organised AI summaries. Its AI goes beyond transcription to identify recurring themes, suggest coping strategies and flag diagnosis markers such as early signs of depression or mania. The product also delivers end-of-session progress notes and analytics that highlight important people and places, plus advanced metrics like client speech cadence, therapist-to-client speech ratio and topic sentiment. Upheal targets therapists and coaches worldwide and aims to free up clinician capacity amid growing demand for mental health care. The company cites therapist time savings (one anonymous therapist estimated 15–20 minutes per client per day, with up to nine clients a day) as a key benefit. Upheal says the recent funding will be used to accelerate product development.

Total raised

$4M

Funding rounds

2

Latest round

Seed

Latest activity

Feb 2024